✦ LIBER ✦

Variant Creutzfeldt–Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty

✍ Scribed by A. Farrugia; J. W. Ironside; P. Giangrande

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Variant Creutzfeldt–Jakob disease: risk

✍ J. W. Ironside; M. W. Head 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Risk reduction strategies for variant Cr

✍ C. PROWSE; B. CUTHBERTSON; M. TURNER 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Managing the risk of transmission of var

✍ Christopher A. Ludlam; Marc L. Turner 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

An update on the assessment and manageme

✍ Marc L. Turner; Christopher A. Ludlam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Risk reduction strategies for variant Cr

✍ C. M. MILLAR; N. CONNOR; G. DOLAN; C. A. LEE; M. MAKRIS; J. WILDE; M. WINTER; J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB